Literature DB >> 26917900

Utility of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in a child with chronic granulomatous disease.

Gunjan Garg1, Raphaella DaSilva1, Avni Bhalakia2, David M Milstein1.   

Abstract

We report the fluorodeoxyglucose positron emission tomography/computed tomography (FDG - PET/CT) findings in an 11-month-old boy with suspected milk protein allergy, presented to the hospital with 2-month history of fever of unknown origin and failure to thrive. It showed FDG avid lymphadenopathy above and below the diaphragm and splenic focus, which could represent diffuse inflammatory process or lymphoma. Subsequent jejunal biopsy showed non-necrotizing granulomas.

Entities:  

Keywords:  Chronic granulomatous disease; fluorodeoxyglucose positron emission tomography/computed tomography; recurrent infection

Year:  2016        PMID： 26917900      PMCID： PMC4746847          DOI： 10.4103/0972-3919.172366

Source DB:  PubMed          Journal:  Indian J Nucl Med        ISSN： 0974-0244


  7 in total

1.  Dramatic Improvement in the Multifocal Positron Emission Tomography Findings of a Young Adult with Chronic Granulomatous Disease Following Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Tomonari Shigemura; Yozo Nakazawa; Koichi Hirabayashi; Norimoto Kobayashi; Kazuo Sakashita; Kazunaga Agematsu; Kenichi Koike
Journal:  J Clin Immunol       Date:  2014-11-04       Impact factor: 8.317

2.  Residual NADPH oxidase and survival in chronic granulomatous disease.

Authors:  Douglas B Kuhns; W Gregory Alvord; Theo Heller; Jordan J Feld; Kristen M Pike; Beatriz E Marciano; Gulbu Uzel; Suk See DeRavin; Debra A Long Priel; Benjamin P Soule; Kol A Zarember; Harry L Malech; Steven M Holland; John I Gallin
Journal:  N Engl J Med       Date:  2010-12-30       Impact factor: 91.245

3.  Killing of pathogens associated with chronic granulomatous disease by the non-oxidative microbicidal mechanisms of human neutrophils.

Authors:  E W Odell; A W Segal
Journal:  J Med Microbiol       Date:  1991-03       Impact factor: 2.472

4.  Diagnostic and therapeutic impact of whole body positron emission tomography using fluorine-18-fluoro-2-deoxy-D-glucose in children with chronic granulomatous disease.

Authors:  T Güngör; I Engel-Bicik; G Eich; U V Willi; D Nadal; J P Hossle; R A Seger; H C Steinert
Journal:  Arch Dis Child       Date:  2001-10       Impact factor: 3.791

5.  Chronic granulomatous disease. Report on a national registry of 368 patients.

Authors:  J A Winkelstein; M C Marino; R B Johnston; J Boyle; J Curnutte; J I Gallin; H L Malech; S M Holland; H Ochs; P Quie; R H Buckley; C B Foster; S J Chanock; H Dickler
Journal:  Medicine (Baltimore)       Date:  2000-05       Impact factor: 1.889

6.  Diagnostic paradigm for evaluation of male patients with chronic granulomatous disease, based on the dihydrorhodamine 123 assay.

Authors:  Orathai Jirapongsananuruk; Harry L Malech; Douglas B Kuhns; Julie E Niemela; Margaret R Brown; Mindy Anderson-Cohen; Thomas A Fleisher
Journal:  J Allergy Clin Immunol       Date:  2003-02       Impact factor: 10.793

7.  Special article: chronic granulomatous disease in the United Kingdom and Ireland: a comprehensive national patient-based registry.

Authors:  L B K R Jones; P McGrogan; T J Flood; A R Gennery; L Morton; A Thrasher; D Goldblatt; L Parker; A J Cant
Journal:  Clin Exp Immunol       Date:  2008-05       Impact factor: 4.330
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.